RE:RE:RE:RE:RE: Next round of financingACTUALLY "fellas" ...
A LOT of "burn rates" have been loe simply because Covid 19 ( the ongoing pandemic ) has slowed recruitment in many ongoing trials and allowed for "burn rates" to be at unrealistic low levels.
This fact has been expsoed at most FDA invloved bio stocks with ongoing trials...I'm not quite as "knowledgeable' as sum of you appear..maybe this one is "different"?
WOW!! .... this must be a very low cost operator. It was my belief they had less than 3M CAD in the kitty and well... with losses and a costly FDA trial underway it would be very impressive it the next round of financing could be pusehed that far back. I will watch closely and hope that these 2023 estimates do in fact play out as per the bullboard's direction. I hope the "bullboard" is right "this time" .... those 55 cent CAD shares must have been particularly pricey the last time everyone ( all three of you ) got sooo bullbiah.